INSIGHTS ON CLINICAL TRIAL DESIGN
-
![early-oncology-trials-GettyImages-1796958784]( "Best Practices For Operationalizing Global, Early-Phase Oncology Trials")
Best Practices For Operationalizing Global, Early-Phase Oncology TrialsIn this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.
-
![early-oncology-trials-GettyImages-1796958784]( "Unanticipated Roadblocks In Ovarian Cancer Drug Development")
Unanticipated Roadblocks In Ovarian Cancer Drug DevelopmentEnhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.
-
![Clinical Leader Solutions Expo]( "Patient Support Solutions For Clinical Trials")
Patient Support Solutions For Clinical TrialsLearn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.
-
![GettyImages-1130765007-eye-research]( "Ocular Endpoint Protection In A Capital-Constrained Market")
Ocular Endpoint Protection In A Capital-Constrained MarketOcular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.
-
How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch5/26/2026
Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?9/17/2025
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
-
Mastering Scope 3 Emissions In Clinical Trials10/23/2024
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
-
How Community-Based Research Models Expand Access9/9/2025
As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1172808955_north america]( "The North American Advantage")
With more than 80% of Avance Clinical’s biotech clients located in North America, the region has played a significant role in the almost three decades of the company’s growth.
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
-
![GettyImages-904483784 doctor patient]( "Clinical Trial Site Selection And Management")
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
![GettyImages-1400967286 regulations computer]( "Mastering Multi-Channel, Multi-Vendor Clinical Trial Recruitment")
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
![GettyImages-1141567619 doctor patient]( "First In Human (FIH) Fact Sheet")
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
